Opinions
Jim Cramer - Mad Money
uniQure
QURE-Q
DON'T BUY
Oct 03, 2025
N/A
Stock price when the opinion was issued
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
They just announced excellent trial results for a drug, but insiders also sold $9 million of shares after their run. It's had a parabolic move. Has too many questions.